Introduction

A b o u k y u a n d E n m e i r a k u , t w o c u l t i v a r s o f e d i b l e
Chrysanthemum spp. (Chrysanthemum morifolium Ramat. forma esculentum Makino), are cultivated in the northeastern region of Honshyu Island, Japan. Enmeiraku is also known by the flower names of Mottenohoka, Omoinohoka or Kakinomoto depending on the region of production. These cultivars are abundantly produced and constitute the major cultivars of edible Chrysanthemum in Japan. In traditional medicine, Chrysanthemum flowers have been used for the treatment of cold symptoms, fever alleviation and detoxification, and brightening of the eyes. Many components of Chrysanthemum flowers have been studied, which have been reported to exhibit various significant pharmacological activities (Ranxin et al., 2004) , including anti-inflammatory, antipyretic, and anti-allergic effects (Xie et al., 2012) , protective effects against brain ischemia, anti-tumorigenic effects, and many other activities, including anti-toxic effects in cancer cells. It has traditionally been held that flavonoid compounds (including luteolin and apigenin) and their glycosides (Chen et al., 1983; Li and Jiang, 2006) , caffeoylquinic acids (Kim and Lee, 2005) , and terpenes are the major active components in Chrysanthemum flowers. Specifically, chlorogenic acid and luteolin are considered to be the most characteristic components of Chrysanthemum flowers (Ranxin et al., 2004; Xie et al., 2012) .
There are over 50 edible Chrysanthemum cultivars in Japan, and numerous studies comparing the various components of Chrysanthemum cultivars have been conducted (Sugawara and Igarashi, 2009; Lin and Harnly, 2010; Xie et al., 2012) . However, to date, comprehensive chemical profiles that characterize cultivar bioactivity have been obscure. In the present study, neuroprotective and neurotrophic effects of the flowers of two typical cultivars of Chrysanthemum, which quantitatively differed in phenolic composition, were compared to examine the correlation between chemical profile and bioactivity.
Living organisms are constantly exposed to oxygen free radicals. Thus, antioxidant defense systems play a role in preventing oxidative damage induced by oxygen free radicals.
However, breakdown of the antioxidant defense system or overproduction of free radicals can result in oxidative damage to biomolecules, leading to various degenerative diseases such as atherosclerosis, cardiovascular disease, and cancer (Uttara et al., 2009) . It has been well established that nerve cells are extremely sensitive to oxidative stress. Toxicity of free radicals contributes to glial cell and neuronal injury, leading to disorders such as Alzheimer's disease, Parkinson's disease, and many other neural disorders. Nutritional studies have shown that the regular consumption of polyphenolic phytochemicals has positive effects on the treatment and prevention of a wide range of oxidative stress injuries and associated pathologies, including cancer, coronary heart disease, and neurodegenerative disease (Bonfili et al., 2008) .
Some of these properties are related to the antioxidative or free radical-scavenging effects of flavonoids. Recently, luteolin, which is a widely distributed flavone in many fruits, vegetables, and Chrysanthemum flowers, has been shown to exhibit protective effects against oxidative stress in neuroblastoma cells and to promote the induction of neurite outgrowth (Lin et al., 2011; Lin et al., 2012) . In light of these findings, we sought to compare the bioactive characteristics of two cultivars of edible Chrysanthemum by analyzing the composition of phenolic components and assessing the neuroprotective and neurotrophic effects of these compounds.
Materials and Methods
Reagents Apigenin, luteolin, tertiary-butyl hydroperoxide (t-BOOH), and MEK inhibitor (U0126) were purchased from Sample preparation Aboukyu and Enmeiraku flowers were cultivated at the same farm in Aomori Prefecture (northeastern region of Japan) and were harvested from mid-October to the beginning of November. The raw Chrysanthemum petals were vacuum dried, powdered, and defatted with hexane at 40℃. The residue was extracted with 80% methanol at 70℃ for 2 h. The filtrate of the extract solvent was evaporated to an adequate concentration under reduced pressure.
Measurement of flavonoid and total phenolic compounds contents
The total phenolic content of the extracts was determined by the Folin-Denis method. Briefly, 0.1 mL of the diluted sample extract was transferred to tubes containing 0.2 mL of Folin-Denis reagent and 3.3 mL of water. After a 10 min rest, 0.4 mL of a saturated sodium carbonate solution was added to the mixture. The tubes were then allowed to stand at room temperature for 30 min before measuring absorbance at 700 nm. The total phenolic content of the extracts was calculated as gallic acid equivalents from the standard graph, and the results were expressed as mg per petal gram (dry weight).
H P L C -D A D a n a l y s i s
H i g h p e r f o r m a n c e l i q u i d chromatography (HPLC) was performed on a Shimadzu LC-10 HPLC coupled to a diode array detector (DAD; Shimadzu Corp.,
Kyoto, Japan). The data were acquired and processed using CLASS-LC10 software (Shimadzu Corp.). The extract was analyzed using a reverse-phase HPLC column: Mightysil RP-18
(150 mm × 4.6 mm, 3 µm) column (Kanto Corp., Tokyo, Japan).
The oven temperature was 40℃ and the flow rate was 0.7 mL/min. Superoxide radical scavenging activity Superoxide radical scavenging activity was determined using a commercial SOD Assay Kit-WST according to the manufacturer's instructions. This method uses the xanthine/xanthine oxidase system to generate superoxide radicals, which react with an electron acceptor t-BOOH was added to the medium at 0.13 _ 0.15 mM after 2 h of pre-treatment with test samples, and cultured for 16 h (Maher and Hanneken, 2005) . Cell viability was evaluated using CCK-8
according to the manufacturer's instructions. The number of viable cells was determined by colorimetric assay using water-soluble 
Western blotting analysis of ERK, phosphorylated ERK, p38
and phosphorylated p38 To assess the activation of extracellular signal-regulated kinase (ERK) and p38 in mitogen activated protein kinase (MAPK) signaling pathway by Chrysanthemum petal extracts, PC12 cells were seeded in collagen-coated 6-well plates at a density of 5 × 10 5 cells/mL in DMEM supplemented with 10%
HS and 5% FBS, and cultured for 24 h. Cells were serum-starved by changing the medium to low serum medium (1% HS and 0.5% Statistical analysis Quantitative data were presented as the mean ± SD. Between group comparisons were analyzed using a Student's t-test. (Table 1) . Aboukyu contained a higher total phenolic compounds content compared to Enmeiraku (21.8 ± 1.07
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vs. 11.4 ± 1.01 mg/g dry weight, respectively). Contents of neuritogenic flavonoids, luteolin and acacetin, in petals were assayed by quantitative HPLC. Apigenin was also assayed because it is one of the characteristic flavonoids in chrysanthemum flowers (Table 1) 
HPLC-DAD characterization of major phenolic components of
Chrysanthemum flowers To characterize the phenolic components in the petals of Chrysanthemum spp. cultivars, Aboukyu and
Enmeiraku petal extracts were subjected to HPLC-DAD (Fig. 2) .
Twelve specific peaks (labeled peaks 1 _ 12) in the HPLC chromatograms were characterized by typical UV absorptions obtained with the DAD, with maximum absorptions (λmax) at 252, 265 _ 268 and 332 _ 348 nm for flavones and at 239, 300 and 326 nm for caffeoylquinic acid derivatives ( Table 2) . Identification of the compounds in Table 2 was made based on a comparison of the retention time and UV spectra for either authenticated standards or previously identified compounds (Wako and Tanikawa, 2004) .
We found that compounds corresponding to six peaks were identified as chlorogenic acid (peak 1), luteolin-7-O-glucoside (peak 2), 3,5-di-caffeoylquinic acid (peak 4), luteolin (peak 8), apigenin (peak 11), and acacetin (peak 12). The compounds corresponding to three peaks (5, 6 and 7) were purportedly luteolin glucosides (peak 6) and apigenin glucosides (peaks 5 and 7) by comparison of UV spectra between these peaks and their aglycone proposed that phenolic compounds are specific nonenzymatic scavengers of superoxides and can prevent biological damage by trapping free radicals such as SOD . We Table 2 . determined the SOD-like activity in order to estimate the antioxidant activities of Aboukyu and Enmeiraku extracts (Fig. 3) .
The SOD level of Aboukyu (IC 50 = 370 μg/mL) was found to be more potent than Enmeiraku (IC 50 = 1060 μg/mL; Fig. 3A ). By contrast, when comparing the values of SOD-like activity by phenolic content weight of the extract, differences in activity levels between the two cultivars was diminished (Aboukyu, IC 50 = 15 μg/ mL; Enmeiraku, IC 50 = 26 μg/mL; Fig. 3B ). These data suggest that the SOD-like antioxidant activity of petals in these cultivars was dependent on the content as well as the composition of phenolic compounds.
Protective effects of Chrysanthemum flower extracts against oxidative stress in SH-SY5Y cells
To compare the protective effect of Aboukyu and Enmeiraku cultivars against oxidative stress, we investigated the effect of the petal extracts on t-BOOH-induced cell death in human neuroblastoma SH-SY5Y cells. Cell viability was assayed using various extract concentrations < 200 µg/mL, levels that did not exhibit cytotoxicity. The cells were cultured for 16 h, and cell viability was determined using the CCK-8 assay.
The cell viability assay showed that the Enmeiraku extract prevented t-BOOH-induced cell death in a concentration-dependent manner from 12.5 to 100 μg/mL (Fig. 4B) . By contrast, the Aboukyu extract affected cell viability in a biphasic manner with increasing concentrations of the extract (Fig. 4A) . At lower concentrations, cell viability was protected from injury, but at concentrations > 25 μg/mL, cell viability decreased. To investigate the differences in the neuroprotective effects between the extracts of Aboukyu and Enmeiraku, we treated SH-SY5Y cells with apigenin and luteolin, since the cultivar extracts contained different levels of those compounds. We also treated SH-SY5Y cells with increasing concentrations of flavonoid compounds (up to 40 µM)
for 16 h and assayed cell viability. Luteolin lowered t-BOOHinduced cell death to control levels at concentrations ranging from 2.5 to 40 µM (Fig. 5B) . In contrast, apigenin partially protected against cell death at concentrations < 5 µM, but impaired cell viability at concentrations > 5 µM (Fig. 5A ). To investigate why apigenin and the Aboukyu extract did not protect SH-SY5Y cells Law et al. (2014) showed that orientin (luteolin-8-C-glucoside) protected SH-SY5Y cells from H 2 O 2 -induced cytotoxicity by decreasing apoptotic cell numbers and inhibiting caspase 3/7 activities. In the present study, the neuroprotective effect of petal extracts from both Aboukyu and Enmeiraku cultivars against oxidative stress was evaluated using SH-SY5Y cells. The Enmeiraku extract (containing 0.08 _ 1 µM of luteolin) showed a significant neuroprotective effect. This may be attributable to decreased neuronal apoptosis due to flavonoids such as luteolin, which is in accordance with the above-mentioned studies reporting similar effects of luteolin glucoside (Fig. 5B ). The differences in the neuroprotective effects of Aboukyu and Enmeiraku extracts might be attributable to the anti-apoptotic capacity of their phenolic compounds as well as compositional differences. Some flavonoids induce apoptosis in cancer cells, and it has been suggested that apigenin-induced apoptosis in 22Rv1 cells is initiated by a ROS-dependent disruption of the mitochondrial membrane potential through the p53 pathway (Shukla and Gupta, 2008) . In the context of our results, we hypothesized that apigenin induced apoptosis in SH-SY5Y neuroblastoma cells in combination with t-BOOH and caused cell injury at higher concentrations (Fig. 5A ). This hypothesis was further supported by the fact that treating the cells with NAC restored oxidative stress injury (Fig. 6) . The impaired neuroprotective effects conferred by the Aboukyu extract at concentrations > 50 µg/mL (containing 0.26 µM apigenin) would therefore also be attributable to apoptosis (Fig. 4A ). This suggests that the levels of flavonoids such as apigenin that easily induce apoptosis were higher in the Aboukyu extract than in the Enmeiraku extract. Thus, the characteristics of the neuroprotective capacity across Chrysanthemum cultivars differed markedly according to the flavonoid composition.
Chrysanthemum flower extracts modulate neurite outgrowth in
PC12 cells Neurotrophic factors such as nerve growth factor
(NGF) play an important role in regulating differentiation, survival, and functional maintenance of nerve cells (Bothwell et al., 1995) .
Moreover, neurotrophic factors regulate microtubule-dependent extension and maintenance. Neurite loss is one of the cardinal features of neuronal injury (Enciu et al., 2011) . Reorganization of lost neuronal networks in the injured brain is necessary for restoration of normal physiological functions (Pesavento et al., 2002) . Because of these properties, neuritogenic substances are anticipated as promising therapeutic tools for the treatment of neuronal injuries. Studies suggest that specific compounds derived from natural sources induce neurite growth (More et al., 2012) .
Nishina et al. found that extracts of Enmeiraku significantly
induced neurite outgrowth in PC12 cells, and the components associated with the neurite outgrowth effects were 3',5,5',7-tetrahy droxylflavanone, luteolin, and acacetin (Nishina et al., 2013) .
Quercetin is also one of the major flavonoids found in Chrysanthemum flowers (Kathy et al., 1993) and exhibits neuritogenic effects (Sagara et al., 2004) .
In the present study, we therefore evaluated the neuritogenic capacity of the petal extracts of Aboukyu and Enmeiraku cultivars.
Incubation of PC12 cells with the two extracts for 24 h showed subtle but significant progressive elongation of neurite-like processes (Fig. 7B, C) . The maximum percentages of neuriteinduced cells attributable to the two extracts were 25.3 ± 2.5%
(Aboukyu) and 26.3 ± 4.0% (Enmeiraku). These percentages were lower than the cells treated with 50 ng/mL NGF (91.7 ± 2.8%) as an endogenous neuritogenic molecule. Luteolin, a typical flavonoid found in Chrysanthemum flowers, exhibits significant neurotrophic activity (Fig. 7E) ; whereas, apigenin, another typical flavonoid, shows poor neurotrophic activity (Fig. 7D) . The Aboukyu extract showed lower concentrations of luteolin than the Enmeiraku extract; however, there were no significant differences in neurite outgrowth induced by the two extracts. A strong correlation between the concentration of neurite growth-inducing flavonoids and neurotrophic activity was previously suggested (Sagara et al., 2004) . To further evaluate the effect of the two extracts on neurite outgrowth, it is necessary to examine other flavonoids that induce neurite outgrowth, such as 3',5,5',7-tetrahydroxylflavanone and quercetin, in addition to luteolin. Previous studies have confirmed the role of natural products in enhancing the neurite outgrowth activity of NGF (Li et al., 2002) . Extracts of Chrysanthemum cultivars only slightly induced neurite outgrowth in our present study; however, the extracts acted synergistically to induce neurite outgrowth in combination with NGF (Fig. 7G, H ). Aboukyu and Enmeiraku extracts, along with 1 ng/mL NGF, synergistically increased the percentages of neurite-induced cells (69.0 ± 6.2% and 63.7 ± 6.7%, respectively). The most effective extract concentration for neurite outgrowth was 100 _ 150 µg/mL. Neurite length also increased by several degrees in cells treated with a combination of Chrysanthemum extracts and NGF compared with those treated with NGF alone (Fig. 7F, G, H) . We did not, however, observe any evident differences in the synergistic effects of Aboukyu and
Enmeiraku extracts on neurite outgrowth activity in combination with NGF.
The MAPK family is a group of serine/threonine protein kinases, including ERKs and p38MAPK, known to be involved in various cellular events such as survival/death, differentiation, and migration (Cobb and Goldsmith, 1995) . Lin et al. suggested that luteolin promotes neurite outgrowth through activation of ERK and PKA signaling pathways in PC12 cells (Lin et al., 2011) . In addition Nishina et al. suggested that luteolin-stimulated neurite extension was augmented by the inhibition of p38MAPK activity (Nishina et al., 2013) . To evaluate the signal transmission pathway for neurite outgrowth during Chrysanthemum extract stimulation,
we examined the effects of a specific inhibitor of ERK, U0126, and an inhibitor of p38, SB203580, on neurite outgrowth induced by two Chrysanthemum extracts in PC12 cells. U0126 treatment significantly inhibited neurite outgrowth induced by Chrysanthemum extracts (Fig. 7 J, K) . SB203580 treatment did not augment neurite extension, although it caused a slight inhibition of neurite outgrowth in the presence of extracts (Fig. 7 M, N) . These results show that ERK is an essential factor in neurite outgrowth during chrysanthemum extract stimulation, whereas p38 is not clearly implicated in PC12 neurogenesis in our experiments. There was no difference in response to these inhibitors in terms of PC12 neurogenesis between Aboukyu and Enmeiraku cultivars.
Activation of ERK and p38MAPK by induction of neurite outgrowth in PC12 cells treated with Chrysanthemum extracts
We also compared the effects of extracts from Aboukyu and (Fig. 8 A) . The ratio of pERK1/2 was higher in cells treated with Aboukyu compared to Enmeiraku. However, as described above, there were no significant differences in neurite outgrowth activity between cells treated with either extract. Watanabe et al. (2012) suggested that phosphorylation of ERK, as an upstream signal, is necessary for neurite outgrowth; however, there was no correlation between the strength of ERK activity and the length of neurite outgrowth. Levels of p-p38MAPK did not change in cells treated with either Chrysanthemum extract (Fig. 8   B) . Flavonoids have been shown to prevent apoptosis via suppression of H 2 O 2 induced p38 activation (Ishikawa and Kitamura, 2000; Choi et al., 2005) . Moreover, studies suggested that phosphorylation of p38MAPK is necessary for neural differentiation (Morooka and Nishida, 1998; Yung et al., 2008) , whereas others suggested that phosphorylation of p38MAPK inhibits neurite outgrowth (Nishina et al., 2013) . Our results did not indicate that the p38MAPK pathway is involved in neurite outgrowth in cells treated with Chrysanthemum extracts.
Conclusion
The recent literature suggests that some natural products capable of eliciting neuritogenic activity may be useful for the treatment of neurological disorders and the maintenance of brain health (More et al., 2012) . Many compounds derived from natural sources have demonstrated neurotrophic and neuroprotective abilities. Nishina et al. found that components of Chrysanthemum flowers induced significant neurite outgrowth in PC12 cells (Nishina et al., 2013) . In the present study, to elucidate differences 
